The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) this month reached a significant new phase of operation, posting research protocols that will lay the groundwork for comparative effectiveness and safety studies of biosimilars currently available or projected to enter the market next year.
Read More
Transitions of Care Pharmacy: Analysis of Pharmacy Interventions to Improve Clinical Outcomes
October 14th 2016West Virginia University Medicine is a 500+ bed academic teaching hospital located in Morgantown, West Virginia. Services offered include a level I trauma center, a level III NICU, and a state-of-the-art cancer center. The hospital has an outpatient pharmacy onsite and in 2012 launched a Transition of Care Pharmacy to offer a bedside consulting service and postdischarge prescription service to any patient within our facility.
Read More
FDA's Warning About Teething Products Gets Quick Response
October 13th 2016In response to the FDA's warning about the safety of homeopathic teething tablets and gels, Hyland's has voluntarily decided to discontinue distributing its teething products in the United States, while CVS has immediately pulled all of its own brand of homeopathic teething products from its shelves, as well as Hyland's and Baby Orajel Naturals.
Read More
FDA Approves FluBlok Quadrivalent Flu Vaccine
October 13th 2016The FDA has approved its quadrivalent formulation of Protein Sciences' Flublok influenza vaccine for protection against 4 strains of influenza-3 of the same strains found in its trivalent version, along with an additional B strain. It is the first high-antigen-content quadrivalent flu vaccine approved by the FDA.
Read More
A comprehensive medication management program designed to optimize therapy and boost adherence to hepatitis C virus medications saved a state Medicaid program nearly $3.8 million in avoided costs, according to a new study in the Journal of Managed Care & Specialty Pharmacy (JMCP).
Read More